Loading…
Getting the latest data.
GMOUS Stock StylesValue#53 of 702 by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | +0.2% | +0.6% | +3.2% | +3.9% | +22.9% | +29.5% | — | — | +39.2% |
| Peer average | +0.1% | +0.6% | +2.3% | +0.2% | +18.8% | +23.5% | +72.4% | +71.6% | — |
| S&P 500 · VOO | −0.3% | −0.6% | −3.6% | −2.7% | +10.9% | +13.1% | +79.3% | +74.2% | — |
$72 of every $1,000 in GMOV is Microsoft
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MSFTMicrosoft | Technology | 7.16% | $716.34 | 14K | $7.6M |
| 2 | METAMETA Platforms | Communication Services | 5.05% | $505.48 | 8,335 | $5.3M |
| 3 | XOMExxonmobil | Energy | 3.55% | $355.05 | 23K | $3.8M |
| 4 | JPMJpmorgan Chase + | Financial Services | 2.66% | $265.59 | 8,211 | $2.8M |
| 5 | MRKMerck + | Healthcare | 2.41% | $241.10 | 17K | $2.5M |
| 6 | VZVerizon Communications | Communication Services | 2.30% | $229.59 | 53K | $2.4M |
| 7 | PFEPfizer | Healthcare | 2.26% | $225.69 | 82K | $2.4M |
| 8 | BMYBristol Myers Squibb | Healthcare | 1.92% | $191.88 | 33K | $2.0M |
| 9 | REGNRegeneron Pharmaceuticals | Healthcare | 1.91% | $191.11 | 2,197 | $2.0M |
| 10 | BACBank OF America | Financial Services | 1.88% | $187.64 | 39K | $2.0M |
| 11 | ADBEAdobe | Technology | 1.85% | $184.97 | 8,243 | $2.0M |
| 12 | CITHE Cigna Group | Healthcare | 1.83% | $183.08 | 6,550 | $1.9M |
| 13 | CVSCVS Health | Healthcare | 1.76% | $176.43 | 22K | $1.9M |
| 14 | PGRProgressive | Financial Services | 1.64% | $163.63 | 7,606 | $1.7M |
| 15 | COFCapital ONE Financial | Financial Services | 1.63% | $162.83 | 8,672 | $1.7M |
of the $464B in 84 Value ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MSFT | Microsoft | 7.16% |
| 2 | META | META Platforms | 5.05% |
| 3 | XOM | Exxonmobil | 3.55% |
| 4 | JPM | Jpmorgan Chase + | 2.66% |
| 5 | MRK | Merck + | 2.41% |
| 6 | VZ | Verizon Communications | 2.30% |
| 7 | PFE | Pfizer | 2.26% |
| 8 | BMY | Bristol Myers Squibb | 1.92% |
| 9 | REGN | Regeneron Pharmaceuticals | 1.91% |
| 10 | BAC | Bank OF America | 1.88% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 30, 2026 | Oct 1, 2026 | $0.17 |
| Jun 30, 2026 | Jul 1, 2026 | $0.13 |
| Mar 31, 2026 | Apr 1, 2026 | $0.17 |
| Dec 30, 2025 | Dec 31, 2025 | $0.14 |
| Sep 30, 2025 | Oct 1, 2025 | $0.15 |
| Jul 1, 2025 | Jul 2, 2025 | $0.15 |
| Mar 31, 2025 | Apr 1, 2025 | $0.10 |
| Dec 30, 2024 | Dec 31, 2024 | $0.0732 |